New Zealand, UK biotech industry associations forge alliance
This article was originally published in RAJ Devices
The biotechnology industry associations of New Zealand and the UK have signed a memorandum of understanding to create a "united voice" for bioscience companies in both countries and enhance economic development between the two regions1.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.